Cargando…
Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481341/ https://www.ncbi.nlm.nih.gov/pubmed/32910359 http://dx.doi.org/10.1007/s11481-020-09956-1 |
_version_ | 1783580580889231360 |
---|---|
author | Maestroni, Georges |
author_facet | Maestroni, Georges |
author_sort | Maestroni, Georges |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7481341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-74813412020-09-10 Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines Maestroni, Georges J Neuroimmune Pharmacol Letter to the Editor Springer US 2020-09-10 2020 /pmc/articles/PMC7481341/ /pubmed/32910359 http://dx.doi.org/10.1007/s11481-020-09956-1 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Maestroni, Georges Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title | Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title_full | Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title_fullStr | Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title_full_unstemmed | Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title_short | Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines |
title_sort | exogenous melatonin as potential adjuvant in anti-sarscov2 vaccines |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481341/ https://www.ncbi.nlm.nih.gov/pubmed/32910359 http://dx.doi.org/10.1007/s11481-020-09956-1 |
work_keys_str_mv | AT maestronigeorges exogenousmelatoninaspotentialadjuvantinantisarscov2vaccines |